The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Antiparasitics Market Research Report 2024
Synopsis
An antiparasitic drug is a substance that kills or inhibits the growth and reproduction of parasites.
Global Antiparasitics market is projected to reach US$ 32450 million in 2029, increasing from US$ 23200 million in 2022, with the CAGR of 5.6% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Antiparasitics market research.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Antiparasitics market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Biosynth Carbosynth
Dechra
SANPHAR
Ipca Laboratories Ltd
Zydus Lifesciences Limited
Merck
Pfizer
GlaxoSmithKline Plc.
Cipla Ltd
Ranbaxy Laboratories
Novartis AG
Alvizia Health Care
Bayer AG
Arbor Pharmaceuticals Inc.
Sanofi
AstraZeneca
Segment by Type
Injectable Forms
Oral Forms
Segment by Application
Animal
Human
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Antiparasitics report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
An antiparasitic drug is a substance that kills or inhibits the growth and reproduction of parasites.
Global Antiparasitics market is projected to reach US$ 32450 million in 2029, increasing from US$ 23200 million in 2022, with the CAGR of 5.6% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Antiparasitics market research.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Antiparasitics market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Biosynth Carbosynth
Dechra
SANPHAR
Ipca Laboratories Ltd
Zydus Lifesciences Limited
Merck
Pfizer
GlaxoSmithKline Plc.
Cipla Ltd
Ranbaxy Laboratories
Novartis AG
Alvizia Health Care
Bayer AG
Arbor Pharmaceuticals Inc.
Sanofi
AstraZeneca
Segment by Type
Injectable Forms
Oral Forms
Segment by Application
Animal
Human
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Antiparasitics report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
Index1 Antiparasitics Market Overview
1.1 Product Overview and Scope of Antiparasitics
1.2 Antiparasitics Segment by Type
1.2.1 Global Antiparasitics Market Value Comparison by Type (2023-2029)
1.2.2 Injectable Forms
1.2.3 Oral Forms
1.3 Antiparasitics Segment by Application
1.3.1 Global Antiparasitics Market Value by Application: (2023-2029)
1.3.2 Animal
1.3.3 Human
1.4 Global Antiparasitics Market Size Estimates and Forecasts
1.4.1 Global Antiparasitics Revenue 2018-2029
1.4.2 Global Antiparasitics Sales 2018-2029
1.4.3 Global Antiparasitics Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Antiparasitics Market Competition by Manufacturers
2.1 Global Antiparasitics Sales Market Share by Manufacturers (2018-2023)
2.2 Global Antiparasitics Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Antiparasitics Average Price by Manufacturers (2018-2023)
2.4 Global Antiparasitics Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Antiparasitics, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Antiparasitics, Product Type & Application
2.7 Antiparasitics Market Competitive Situation and Trends
2.7.1 Antiparasitics Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Antiparasitics Players Market Share by Revenue
2.7.3 Global Antiparasitics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Antiparasitics Retrospective Market Scenario by Region
3.1 Global Antiparasitics Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Antiparasitics Global Antiparasitics Sales by Region: 2018-2029
3.2.1 Global Antiparasitics Sales by Region: 2018-2023
3.2.2 Global Antiparasitics Sales by Region: 2024-2029
3.3 Global Antiparasitics Global Antiparasitics Revenue by Region: 2018-2029
3.3.1 Global Antiparasitics Revenue by Region: 2018-2023
3.3.2 Global Antiparasitics Revenue by Region: 2024-2029
3.4 North America Antiparasitics Market Facts & Figures by Country
3.4.1 North America Antiparasitics Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Antiparasitics Sales by Country (2018-2029)
3.4.3 North America Antiparasitics Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Antiparasitics Market Facts & Figures by Country
3.5.1 Europe Antiparasitics Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Antiparasitics Sales by Country (2018-2029)
3.5.3 Europe Antiparasitics Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Antiparasitics Market Facts & Figures by Country
3.6.1 Asia Pacific Antiparasitics Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Antiparasitics Sales by Country (2018-2029)
3.6.3 Asia Pacific Antiparasitics Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Antiparasitics Market Facts & Figures by Country
3.7.1 Latin America Antiparasitics Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Antiparasitics Sales by Country (2018-2029)
3.7.3 Latin America Antiparasitics Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Antiparasitics Market Facts & Figures by Country
3.8.1 Middle East and Africa Antiparasitics Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Antiparasitics Sales by Country (2018-2029)
3.8.3 Middle East and Africa Antiparasitics Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Antiparasitics Sales by Type (2018-2029)
4.1.1 Global Antiparasitics Sales by Type (2018-2023)
4.1.2 Global Antiparasitics Sales by Type (2024-2029)
4.1.3 Global Antiparasitics Sales Market Share by Type (2018-2029)
4.2 Global Antiparasitics Revenue by Type (2018-2029)
4.2.1 Global Antiparasitics Revenue by Type (2018-2023)
4.2.2 Global Antiparasitics Revenue by Type (2024-2029)
4.2.3 Global Antiparasitics Revenue Market Share by Type (2018-2029)
4.3 Global Antiparasitics Price by Type (2018-2029)
5 Segment by Application
5.1 Global Antiparasitics Sales by Application (2018-2029)
5.1.1 Global Antiparasitics Sales by Application (2018-2023)
5.1.2 Global Antiparasitics Sales by Application (2024-2029)
5.1.3 Global Antiparasitics Sales Market Share by Application (2018-2029)
5.2 Global Antiparasitics Revenue by Application (2018-2029)
5.2.1 Global Antiparasitics Revenue by Application (2018-2023)
5.2.2 Global Antiparasitics Revenue by Application (2024-2029)
5.2.3 Global Antiparasitics Revenue Market Share by Application (2018-2029)
5.3 Global Antiparasitics Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Biosynth Carbosynth
6.1.1 Biosynth Carbosynth Corporation Information
6.1.2 Biosynth Carbosynth Description and Business Overview
6.1.3 Biosynth Carbosynth Antiparasitics Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Biosynth Carbosynth Antiparasitics Product Portfolio
6.1.5 Biosynth Carbosynth Recent Developments/Updates
6.2 Dechra
6.2.1 Dechra Corporation Information
6.2.2 Dechra Description and Business Overview
6.2.3 Dechra Antiparasitics Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Dechra Antiparasitics Product Portfolio
6.2.5 Dechra Recent Developments/Updates
6.3 SANPHAR
6.3.1 SANPHAR Corporation Information
6.3.2 SANPHAR Description and Business Overview
6.3.3 SANPHAR Antiparasitics Sales, Revenue and Gross Margin (2018-2023)
6.3.4 SANPHAR Antiparasitics Product Portfolio
6.3.5 SANPHAR Recent Developments/Updates
6.4 Ipca Laboratories Ltd
6.4.1 Ipca Laboratories Ltd Corporation Information
6.4.2 Ipca Laboratories Ltd Description and Business Overview
6.4.3 Ipca Laboratories Ltd Antiparasitics Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Ipca Laboratories Ltd Antiparasitics Product Portfolio
6.4.5 Ipca Laboratories Ltd Recent Developments/Updates
6.5 Zydus Lifesciences Limited
6.5.1 Zydus Lifesciences Limited Corporation Information
6.5.2 Zydus Lifesciences Limited Description and Business Overview
6.5.3 Zydus Lifesciences Limited Antiparasitics Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Zydus Lifesciences Limited Antiparasitics Product Portfolio
6.5.5 Zydus Lifesciences Limited Recent Developments/Updates
6.6 Merck
6.6.1 Merck Corporation Information
6.6.2 Merck Description and Business Overview
6.6.3 Merck Antiparasitics Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Merck Antiparasitics Product Portfolio
6.6.5 Merck Recent Developments/Updates
6.7 Pfizer
6.6.1 Pfizer Corporation Information
6.6.2 Pfizer Description and Business Overview
6.6.3 Pfizer Antiparasitics Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Pfizer Antiparasitics Product Portfolio
6.7.5 Pfizer Recent Developments/Updates
6.8 GlaxoSmithKline Plc.
6.8.1 GlaxoSmithKline Plc. Corporation Information
6.8.2 GlaxoSmithKline Plc. Description and Business Overview
6.8.3 GlaxoSmithKline Plc. Antiparasitics Sales, Revenue and Gross Margin (2018-2023)
6.8.4 GlaxoSmithKline Plc. Antiparasitics Product Portfolio
6.8.5 GlaxoSmithKline Plc. Recent Developments/Updates
6.9 Cipla Ltd
6.9.1 Cipla Ltd Corporation Information
6.9.2 Cipla Ltd Description and Business Overview
6.9.3 Cipla Ltd Antiparasitics Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Cipla Ltd Antiparasitics Product Portfolio
6.9.5 Cipla Ltd Recent Developments/Updates
6.10 Ranbaxy Laboratories
6.10.1 Ranbaxy Laboratories Corporation Information
6.10.2 Ranbaxy Laboratories Description and Business Overview
6.10.3 Ranbaxy Laboratories Antiparasitics Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Ranbaxy Laboratories Antiparasitics Product Portfolio
6.10.5 Ranbaxy Laboratories Recent Developments/Updates
6.11 Novartis AG
6.11.1 Novartis AG Corporation Information
6.11.2 Novartis AG Antiparasitics Description and Business Overview
6.11.3 Novartis AG Antiparasitics Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Novartis AG Antiparasitics Product Portfolio
6.11.5 Novartis AG Recent Developments/Updates
6.12 Alvizia Health Care
6.12.1 Alvizia Health Care Corporation Information
6.12.2 Alvizia Health Care Antiparasitics Description and Business Overview
6.12.3 Alvizia Health Care Antiparasitics Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Alvizia Health Care Antiparasitics Product Portfolio
6.12.5 Alvizia Health Care Recent Developments/Updates
6.13 Bayer AG
6.13.1 Bayer AG Corporation Information
6.13.2 Bayer AG Antiparasitics Description and Business Overview
6.13.3 Bayer AG Antiparasitics Sales, Revenue and Gross Margin (2018-2023)
6.13.4 Bayer AG Antiparasitics Product Portfolio
6.13.5 Bayer AG Recent Developments/Updates
6.14 Arbor Pharmaceuticals Inc.
6.14.1 Arbor Pharmaceuticals Inc. Corporation Information
6.14.2 Arbor Pharmaceuticals Inc. Antiparasitics Description and Business Overview
6.14.3 Arbor Pharmaceuticals Inc. Antiparasitics Sales, Revenue and Gross Margin (2018-2023)
6.14.4 Arbor Pharmaceuticals Inc. Antiparasitics Product Portfolio
6.14.5 Arbor Pharmaceuticals Inc. Recent Developments/Updates
6.15 Sanofi
6.15.1 Sanofi Corporation Information
6.15.2 Sanofi Antiparasitics Description and Business Overview
6.15.3 Sanofi Antiparasitics Sales, Revenue and Gross Margin (2018-2023)
6.15.4 Sanofi Antiparasitics Product Portfolio
6.15.5 Sanofi Recent Developments/Updates
6.16 AstraZeneca
6.16.1 AstraZeneca Corporation Information
6.16.2 AstraZeneca Antiparasitics Description and Business Overview
6.16.3 AstraZeneca Antiparasitics Sales, Revenue and Gross Margin (2018-2023)
6.16.4 AstraZeneca Antiparasitics Product Portfolio
6.16.5 AstraZeneca Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Antiparasitics Industry Chain Analysis
7.2 Antiparasitics Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Antiparasitics Production Mode & Process
7.4 Antiparasitics Sales and Marketing
7.4.1 Antiparasitics Sales Channels
7.4.2 Antiparasitics Distributors
7.5 Antiparasitics Customers
8 Antiparasitics Market Dynamics
8.1 Antiparasitics Industry Trends
8.2 Antiparasitics Market Drivers
8.3 Antiparasitics Market Challenges
8.4 Antiparasitics Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
